2,220 research outputs found

    Synthetic precursor to make alkali activated cements

    Get PDF
    Please click Additional Files below to see the full abstract

    Biomass derived activated carbon catalysts for the one-step dimethyl ether synthesis from syngas

    Get PDF
    Se trata de un resumen extendido de una comunicación a congreso internacional.In this work we study the behaviour of a carbon-based catalyst for this one-step synthesis process. Two kinds of activated carbons, prepared by chemical (with H3PO4) and physical (by CO2 partial gasification) activation of olive stones, were used as catalysts support. The main difference between the activated carbons was the presence of chemically stable phosphorus surface groups, mainly in form of C-O-PO3 groups1, on the activated carbon prepared via chemical activation. The addition of Zr to the chemically activated carbon (ACPZr) resulted in the formation of zirconium phosphate species on the carbon surface, which were capable of promoting the selective methanol dehydration to DME. Cu-Zn loading on the chemically activated carbon resulted in strong interactions between the metallic phase and the phosphate surface groups due to the formation Cu phosphate species. The bifunctional catalyst, ACPZrCuZn showed less conversion that the physical mixture. This fact is related with the presence of phosphorus species that avoids the reduction of the metal (copper).Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech

    Conservation biogeography of ecologically interacting species: The case of the Iberian lynx and the European rabbit

    Get PDF
    Aim To relate the recent Iberian lynx decline to changes in the distribution of the European rabbit after the haemorrhagic disease outbreak of 1989. As Iberian rabbits evolved in two geographically separated lineages, being the recent lynx range practically restricted to the southwestern lineage, we also test if differential range dynamics exists for these lineages, with the consequent implications for lynx conservation and reintroduction planning

    Influencia de la longitud de la biela en la eficiencia y biomecánica del pedaleo submáximo

    Get PDF
    El principal objetivo de este estudio es analizar el efecto de pequeños cambios en la longitud de la biela en el gasto energético y la técnica de pedaleo submáximo. Participaron 12 ciclistas de fondo en carretera bien entrenados, que realizaron pruebas de pedaleo a tres potencias con cadencia estable, utilizando tres longitudes de biela (en orden aleatorio). Sus bicicletas fueron exactamente reproducidas en un ergómetro que medía el torque ejercido sobre la biela izquierda y derecha de forma independiente. Simultáneamente se registró cinemática 2D de la pierna derecha y el gasto energético al pedalear (eficiencia gruesa). Los resultados muestran que los cambios en la longitud de la biela no tuvieron efecto en la eficiencia gruesa, pero sí en las variables biomecánicas. Una biela de mayor longitud provocó una pérdida de eficiencia mecánica y un aumento en la flexión y el rango de movimiento de la cadera y la rodilla, sin cambios en el tobillo. Aunque estos cambios no fueron lo suficientemente importantes para alterar la eficiencia gruesa, sí que podrían tener implicaciones negativas a largo plazo (peor técnica de pedaleo y riesgo de lesión). En conclusión, el efecto de pequeños cambios en la longitud de la biela, que serían asumibles por ciclistas de competición, producen alteraciones en la biomecánica de pedaleo, pero no en su eficiencia gruesa. Futuros estudios deben abordar los efectos a largo plazo de estos cambios.The main purpose of this study was to analyze the effects of small changes in crank length on gross efficiency and pedaling technique during submaximal cycling. Twelve well-trained road cyclists participated. They pedaled at three power outputs and steady cadence with three crank lengths (in a randomized order). Their bicycles were exactly reproduced on an ergometer where crank torque of the left and right legs were independently registered. 2D kinematic of the right leg and energy cost (gross efficiency) were recorded. The results showed that changes in crank length had no effect on the gross efficiency, but had effect on the biomechanical variables. A longer crank caused a decreased in mechanical efficiency and an increase in the flexion and range of movement of the hip and the knee, without changes in the ankle. These alterations were not significant enough to alter the gross efficiency, but they could have negative long-term implications (worse pedaling technique and possible injuries). In conclusion, the small changes in crank arm length which are feasible for competitive cyclists affected cycling biomechanics, but not gross efficiency. Future studies should study long-term effects of these changes.Peer Reviewe

    Bases psicobiológicas de la adicción a cocaína

    Get PDF
    El principal mecanismo de acción de la cocaína es la inhibición de la recaptación de dopamina y noradrenalina, produciendo un aumento de estos neurotransmisores en la sinapsis. El consumo agudo de cocaína produce una serie de cambios bastante conocidos en el sistema cerebral de recompensa. Sin embargo, el consumo crónico, produce, además, otra serie de cambios a nivel molecular que llevan al sujeto desde una situación de consumo puntual, a una situación de dependencia. Se han propuesto diferentes teorías explicativas de este fenómeno como la sensibilización del incentivo, o la homeostasis y alostasis neuroquímica, planteamientos basados en el condicionamiento clásico y operante. Por otra parte, se ha señalado la intervención de diferentes moléculas y vías de segundos mensajeros, que producen, en última instancia, una serie de cambios neuronales mantenidos a muy largo plazo, probablemente permanentes, que se podrían relacionar con la vulnerabilidad a las recaídas, propia de la adicción a cocaína, incluso años después de abandonar el consumo

    Lessons learned from supplementing archaeological museum exhibitions with virtual reality

    Get PDF
    Archaeological excavations provide us with important clues about the past. Excavated artefacts represent an important connection to civilisations that no longer exist and help us understand some of their customs, traditions and common practices. With the help of academics and practitioners from various disciplines the results of archaeological excavations can be analysed and a body of knowledge about the corresponding society can be created and shared with members of the general public. Museums have traditionally served the purpose of communicating this knowledge and backing it up with the help of the excavated artefacts. Many museum visitors, however, find it difficult to develop a coherent understanding of the corresponding society only based on the artefacts and annotations showed in museums. Effective modern techniques that have high potential in helping museum visitors with better understanding of the past are 3D reconstruction and Virtual Reality. 3D reconstruction offers a cost effective way of recreating historical settlements in a computer-generated virtual environment, while Virtual Reality helps with immersing people into such environments and reaching a high degree of realism. With the help of these technologies it becomes possible to relive history, imagine yourself being a part of the reconstructed society and learn about its culture firsthand. The combination of 3D reconstruction and Virtual Reality \anton{represents} a very powerful learning tool, however this tool has been rarely used in a museum setting and its correct use has not been properly investigated. In this paper we present a study into using Virtual Reality in itinerant archaeological exhibitions. We discuss the lessons we have learned from developing an interactive Virtual Reality simulation of the Neolithic settlement of La Draga. These lessons feature our analysis of qualitative and quantitative feedback of museum visitors, as well as what we have learned from analysing their navigation and interaction patterns

    On the relationship between subjective and objective measures of virtual reality experiences : a case study of a serious game

    Get PDF
    In this paper we present a Virtual Reality game related to Cultural Heritage. We contribute with an analysis of subjective measures taken from questionnaires filled by users after the VR experience, and objective measures taken from logs during the VR game. Specifically, we were interested on study data globally and in groups of user behaviour. Analysing data globally we see a high value of users’ subjective perceptions. Nevertheless, we found differences of subjective measures when splitting the Novice group. Specifically, the subjective perception of Strugglers is considerably lower than the rest of groups, and this difference is significant. Then, we propose strategies to provide a better experience to Strugglers. We also found correlations between objective and subjective data when they were analysed globally (i.e. without using groups), but these measures did not correlate when they were analysed using behaviour groups

    CADICA: a new dataset for coronary artery disease detection by using invasive coronary angiography

    Full text link
    Coronary artery disease (CAD) remains the leading cause of death globally and invasive coronary angiography (ICA) is considered the gold standard of anatomical imaging evaluation when CAD is suspected. However, risk evaluation based on ICA has several limitations, such as visual assessment of stenosis severity, which has significant interobserver variability. This motivates to development of a lesion classification system that can support specialists in their clinical procedures. Although deep learning classification methods are well-developed in other areas of medical imaging, ICA image classification is still at an early stage. One of the most important reasons is the lack of available and high-quality open-access datasets. In this paper, we reported a new annotated ICA images dataset, CADICA, to provide the research community with a comprehensive and rigorous dataset of coronary angiography consisting of a set of acquired patient videos and associated disease-related metadata. This dataset can be used by clinicians to train their skills in angiographic assessment of CAD severity and by computer scientists to create computer-aided diagnostic systems to help in such assessment. In addition, baseline classification methods are proposed and analyzed, validating the functionality of CADICA and giving the scientific community a starting point to improve CAD detection

    EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

    Get PDF
    [EN] Introduction: Durvalumab received EMA approval as consolidation therapy (CT) for unresectable stage III NSCLC with PD-L1 _1% and who did not have progression after CRT. Our objective was to analyze in real clinical practice the effectiveness of durvalumab and explore the clinical factors that may be associated with the benefit from CT. Methods: Retrospective study was made at Hospital of Leon (Spain), including 37 patients with locally advanced NSCLC treated with durvalumab after CRT treatment between March 2018 and october 2021 (40.5% patients were included in the durvalumab early access program). The neutrophil-to-lymphocyte ratio (NLR) could identified after CRT as a factor that may be benefit from durvalumab. Results: Median age was 67 years (range 46-82 years). 40.5% of patients were _70 years old. 78.4% were male and 51.4% smokers. 54% had non-squamous histology. PD-L1 expression was <1% in 5% and not available in 8% patients. 2.7% ROS1 rearrangements, 5.4% KRAS mutations and not available in 43.2% patients. Stage IIIA, IIIB, IIIC disease were 24.3%, 54.1% and 21.6%, respectively. Median time from end of CRT to onset durvalumab was 44 days (range 13-120 days). Overall median CT duration was 214.8 days (range 69-399 days) with a median of 14 infusions (range 6-27 infusions). With a median follow up of 19.7 months (range 1.4-34.9 months); 67.6% had stopped CT: 37.8% due to completing treatment, 16.2% disease progression, 10.8% adverse event and 2.7% due to COVID19 infection. Median real-world progressionfree survival (rwPFS) was 17 months (95% CI, 11-23). Median realworld overall survival (rwOS) was 29.9 months (95% CI, 23.3-36.6). % rwOS at 6, 18 and 24 months were 100%, 86.9% and 74.5%, respectively. For patients with post-CRT NLR not exceeding the cohort median value of 6, receipt of durvalumab was associated with an improvement in rwOS (median not reached vs 25.7 months; p¼0.025). 56.8% patients had any grade of radiation pneumonitis (median time from CRT start: 119 days [range 36-241 days]). Of these, 19% patients developed worsening of radiation pneumonitis with durvalumab. 54,1% developed immune-mediated toxicity, mostly G1-2 (85.1%). Conclusions: Our results demonstrate the effectiveness of durvalumab consolidation in this patients population in a real-life setting. We identified low NLR after CRT as a potentially predictive factor for the benefit of CT in locally advanced NSCLC.S

    Subtly modulating glycogen synthase kinase 3 ß: Allosteric inhibitor development and their potential for the treatment of chronic diseases

    Get PDF
    Glycogen synthase kinase 3 ß (GSK-3ß) is a central target in several unmet diseases. To increase the specificity of GSK-3ß inhibitors in chronic treatments, we developed small molecules allowing subtle modulation of GSK-3ß activity. Design synthesis, structure¿activity relationships, and binding mode of quinoline-3-carbohydrazide derivatives as allosteric modulators of GSK-3ß are presented here. Furthermore, we show how allosteric binders may overcome the ß-catenin side effects associated with strong GSK-3ß inhibition. The therapeutic potential of some of these modulators has been tested in human samples from patients with congenital myotonic dystrophy type 1 (CDM1) and spinal muscular atrophy (SMA) patients. We found that compound 53 improves delayed myogenesis in CDM1 myoblasts, while compounds 1 and 53 have neuroprotective properties in SMA-derived cells. These findings suggest that the allosteric modulators of GSK-3ß may be used for future development of drugs for DM1, SMA, and other chronic diseases where GSK-3ß inhibition exhibits therapeutic effects.This work was financially supported by MINECO (grant no. SAF2012-37979-C03-01 and SAF2016-76693-R to A.M. and IJCI-2014-20767 to V.P.). CCHMC funds L.T. A.M. and C.G. are members of the CIB Intramural Program “Molecular Machines for Better Life” (MACBET).Peer Reviewe
    corecore